Please enable JavaScript to continue using this application.

Compare $ARCT vs $USBC | Chartloom

Compare

$ARCT vs $USBC

Arcturus Therapeutics Holdings Inc · USBC Inc

ARCT

Arcturus Therapeutics Holdings Inc

USBC

USBC Inc

Compare $ARCT vs $USBC

Comparing Arcturus Therapeutics Holdings Inc and USBC Inc

ARCTArcturus Therapeutics Holdings Inc

USBCUSBC Inc

ARCTArcturus Therapeutics Holdings Inc

Market cap

$390M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.64x

Rev growth (TTM)

-76.0%

YTD performance

119.8%

52W performance

-35.2%

FCF yield

-18.7%

USBCUSBC Inc

Market cap

$198M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-22.2%

52W performance

-51.9%

FCF yield

-11.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ARCT

USBC

Detailed metrics comparison

ARCT

Arcturus Therapeutics Holdings Inc

USBC

USBC Inc

Market Cap

ARCT$390M

USBC$198M

Enterprise Value

ARCT$199M

USBC$210M

Price

ARCT$13.74

USBC$0.51

P/E Ratio

ARCTN/A

USBCN/A

P/S Ratio

ARCT13.30x

USBC0.00x

EV/Sales

ARCT6.78x

USBC0.00x

EV/EBITDA

ARCT1.82x

USBC0.00x

P/B Ratio

ARCT2.16x

USBC4.46x

P/FCF Ratio

ARCTN/A

USBCN/A

EV/FCF

ARCT-2.73x

USBC-9.14x

PEG Ratio

ARCTN/A

USBCN/A

Forward P/E (NTM)

ARCTN/A

USBCN/A

Forward P/S (NTM)

ARCT21.64x

USBCN/A

Revenue (TTM)

ARCT$29M

USBC$0

Revenue Growth (YoY)

ARCT-76.0%

USBCN/A

Forward Rev Growth

ARCT107.7%

USBC0.0%

Gross Margin (TTM)

ARCT0.0%

USBC0.0%

Operating Margin (TTM)

ARCT0.0%

USBC0.0%

EBITDA Margin (TTM)

ARCT-339.0%

USBC0.0%

Net Margin (TTM)

ARCT-317.6%

USBC0.0%

FCF Margin (TTM)

ARCT-248.6%

USBCN/A

Net Income (TTM)

ARCT$-93M

USBC$-86M

FCF (TTM)

ARCT$-73M

USBC$-23M

EPS (TTM)

ARCT-$3.28

USBC-$0.22

ROE (TTM)

ARCT-4654.0%

USBC-12093.0%

ROA (TTM)

ARCT-3646.0%

USBC-9639.0%

ROIC (TTM)

ARCT-4654.0%

USBC-11297.0%

Cash

ARCT$191M

USBC$3M

Debt

ARCT$0

USBC$15M

Net Cash/Debt

ARCT$191M

USBC$-12M

Current Ratio (TTM)

ARCT5.88x

USBC0.23x

Quick Ratio (TTM)

ARCT5.76x

USBC0.20x

Debt/Equity (TTM)

ARCT0.00x

USBC0.32x

Debt/Assets (TTM)

ARCT0.0%

USBC0.0%

Interest Coverage (TTM)

ARCTN/A

USBCN/A

Net Debt/EBITDA (TTM)

ARCT0.00x

USBC0.00x

Beta

ARCT2.60

USBC2.77

52W Performance

ARCT-35.2%

USBC-51.9%

YTD Performance

ARCT119.8%

USBC-22.2%

% from 52W High

ARCT-43.2%

USBC-60.5%

% from 52W Low

ARCT149.8%

USBC78.7%

Asset Turnover (TTM)

ARCT0.11x

USBC0.00x

FCF Yield (TTM)

ARCT-18.7%

USBC-11.6%

Earnings Yield (TTM)

ARCT-23.9%

USBC-43.5%

Dividend Yield (TTM)

ARCTN/A

USBCN/A

Rule of 40

ARCT-324.5

USBC0.0

EV/GP/RG

ARCTN/A

USBCN/A

Ticker research

View ARCT research View USBC research

Metric	ARCT Arcturus Therapeutics Holdings Inc	USBC USBC Inc
Market & Valuation
Market Cap	$390M	$198M
Enterprise Value	$199M	$210M
Price	$13.74	$0.51
P/E Ratio	N/A	N/A
P/S Ratio	13.30x	0.00x
EV/Sales	6.78x	0.00x
EV/EBITDA	1.82x	0.00x
P/B Ratio	2.16x	4.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.73x	-9.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.64x	N/A
Revenue & Growth
Revenue (TTM)	$29M	$0
Revenue Growth (YoY)	-76.0%	N/A
Forward Rev Growth	107.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-339.0%	0.0%
Net Margin (TTM)	-317.6%	0.0%
FCF Margin (TTM)	-248.6%	N/A
Net Income (TTM)	$-93M	$-86M
FCF (TTM)	$-73M	$-23M
EPS (TTM)	-$3.28	-$0.22
ROE (TTM)	-4654.0%	-12093.0%
ROA (TTM)	-3646.0%	-9639.0%
ROIC (TTM)	-4654.0%	-11297.0%
Financial Health
Cash	$191M	$3M
Debt	$0	$15M
Net Cash/Debt	$191M	$-12M
Current Ratio (TTM)	5.88x	0.23x
Quick Ratio (TTM)	5.76x	0.20x
Debt/Equity (TTM)	0.00x	0.32x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	2.77
52W Performance	-35.2%	-51.9%
YTD Performance	119.8%	-22.2%
% from 52W High	-43.2%	-60.5%
% from 52W Low	149.8%	78.7%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-18.7%	-11.6%
Earnings Yield (TTM)	-23.9%	-43.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-324.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARCT research	View USBC research

Valuation

P/S Ratio

USBC

0.00x

ARCT

13.30x

EV/FCF

USBC

-9.14x

ARCT

-2.73x

Growth & revenue

Revenue Growth TTM

ARCT

-76.0%

Forward Revenue Growth

ARCT

107.7%

USBC

0.0%

Profitability & performance

Gross Margin

ARCT

0.0%

USBC

0.0%

ROE

ARCT

-4654.0%

USBC

-12093.0%

FCF Yield %

USBC

-11.6%

ARCT

-18.7%

52-Week Performance

ARCT

-35.2%

USBC

-51.9%

Detailed metrics comparison

ARCT

Arcturus Therapeutics Holdings Inc

USBC

USBC Inc

Market Cap

ARCT$390M

USBC$198M

Enterprise Value

ARCT$199M

USBC$210M

Price

ARCT$13.74

USBC$0.51

P/E Ratio

ARCTN/A

USBCN/A

P/S Ratio

ARCT13.30x

USBC0.00x

EV/Sales

ARCT6.78x

USBC0.00x

EV/EBITDA

ARCT1.82x

USBC0.00x

P/B Ratio

ARCT2.16x

USBC4.46x

P/FCF Ratio

ARCTN/A

USBCN/A

EV/FCF

ARCT-2.73x

USBC-9.14x

PEG Ratio

ARCTN/A

USBCN/A

Forward P/E (NTM)

ARCTN/A

USBCN/A

Forward P/S (NTM)

ARCT21.64x

USBCN/A

Revenue (TTM)

ARCT$29M

USBC$0

Revenue Growth (YoY)

ARCT-76.0%

USBCN/A

Forward Rev Growth

ARCT107.7%

USBC0.0%

Gross Margin (TTM)

ARCT0.0%

USBC0.0%

Operating Margin (TTM)

ARCT0.0%

USBC0.0%

EBITDA Margin (TTM)

ARCT-339.0%

USBC0.0%

Net Margin (TTM)

ARCT-317.6%

USBC0.0%

FCF Margin (TTM)

ARCT-248.6%

USBCN/A

Net Income (TTM)

ARCT$-93M

USBC$-86M

FCF (TTM)

ARCT$-73M

USBC$-23M

EPS (TTM)

ARCT-$3.28

USBC-$0.22

ROE (TTM)

ARCT-4654.0%

USBC-12093.0%

ROA (TTM)

ARCT-3646.0%

USBC-9639.0%

ROIC (TTM)

ARCT-4654.0%

USBC-11297.0%

Cash

ARCT$191M

USBC$3M

Debt

ARCT$0

USBC$15M

Net Cash/Debt

ARCT$191M

USBC$-12M

Current Ratio (TTM)

ARCT5.88x

USBC0.23x

Quick Ratio (TTM)

ARCT5.76x

USBC0.20x

Debt/Equity (TTM)

ARCT0.00x

USBC0.32x

Debt/Assets (TTM)

ARCT0.0%

USBC0.0%

Interest Coverage (TTM)

ARCTN/A

USBCN/A

Net Debt/EBITDA (TTM)

ARCT0.00x

USBC0.00x

Beta

ARCT2.60

USBC2.77

52W Performance

ARCT-35.2%

USBC-51.9%

YTD Performance

ARCT119.8%

USBC-22.2%

% from 52W High

ARCT-43.2%

USBC-60.5%

% from 52W Low

ARCT149.8%

USBC78.7%

Asset Turnover (TTM)

ARCT0.11x

USBC0.00x

FCF Yield (TTM)

ARCT-18.7%

USBC-11.6%

Earnings Yield (TTM)

ARCT-23.9%

USBC-43.5%

Dividend Yield (TTM)

ARCTN/A

USBCN/A

Rule of 40

ARCT-324.5

USBC0.0

EV/GP/RG

ARCTN/A

USBCN/A

Ticker research

View ARCT research View USBC research

Metric	ARCT Arcturus Therapeutics Holdings Inc	USBC USBC Inc
Market & Valuation
Market Cap	$390M	$198M
Enterprise Value	$199M	$210M
Price	$13.74	$0.51
P/E Ratio	N/A	N/A
P/S Ratio	13.30x	0.00x
EV/Sales	6.78x	0.00x
EV/EBITDA	1.82x	0.00x
P/B Ratio	2.16x	4.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.73x	-9.14x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.64x	N/A
Revenue & Growth
Revenue (TTM)	$29M	$0
Revenue Growth (YoY)	-76.0%	N/A
Forward Rev Growth	107.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-339.0%	0.0%
Net Margin (TTM)	-317.6%	0.0%
FCF Margin (TTM)	-248.6%	N/A
Net Income (TTM)	$-93M	$-86M
FCF (TTM)	$-73M	$-23M
EPS (TTM)	-$3.28	-$0.22
ROE (TTM)	-4654.0%	-12093.0%
ROA (TTM)	-3646.0%	-9639.0%
ROIC (TTM)	-4654.0%	-11297.0%
Financial Health
Cash	$191M	$3M
Debt	$0	$15M
Net Cash/Debt	$191M	$-12M
Current Ratio (TTM)	5.88x	0.23x
Quick Ratio (TTM)	5.76x	0.20x
Debt/Equity (TTM)	0.00x	0.32x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.60	2.77
52W Performance	-35.2%	-51.9%
YTD Performance	119.8%	-22.2%
% from 52W High	-43.2%	-60.5%
% from 52W Low	149.8%	78.7%
Efficiency & Yields
Asset Turnover (TTM)	0.11x	0.00x
FCF Yield (TTM)	-18.7%	-11.6%
Earnings Yield (TTM)	-23.9%	-43.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-324.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ARCT research	View USBC research